Related Experiment Video
Updated: Jan 10, 2026

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
Published on: May 11, 2014
Challenges in Endoscopic Eradication Therapy: Refractory and Recurrent Barrett's Esophagus
Kevin P Shah1, Vismaya Bachu2, Shirin Dey3
1Department of Gastroenterology and Hepatology, Northwestern Memorial Hospital, Chicago, IL, USA.
Endoscopic eradication therapy (EET) effectively treats intestinal metaplasia but faces challenges with refractory and recurrent Barrett's esophagus (BE). Addressing risk factors and careful salvage therapy are key for successful BE management.
Area of Science:
- Gastroenterology
- Endoscopy
- Oncology
Background:
- Intestinal metaplasia management has advanced with endoscopic eradication therapy (EET).
- Barrett's esophagus (BE) and associated dysplasia require effective treatment strategies.
- Refractory and recurrent BE present ongoing clinical challenges.
Purpose of the Study:
- To review the current state of endoscopic eradication therapy (EET) for Barrett's esophagus (BE).
- To highlight challenges and management principles for refractory and recurrent BE.
- To emphasize the importance of addressing modifiable risk factors and potential adverse effects.
Main Methods:
- Review of current endoscopic eradication therapy (EET) techniques.
- Discussion of multimodal approaches including endoscopic resection and ablative therapy.
- Analysis of management strategies for refractory and recurrent Barrett's esophagus (BE).
Main Results:
- Endoscopic eradication therapy (EET) has improved complete eradication of intestinal metaplasia.
- A multimodal approach is the standard for BE and BE-related dysplasia.
- Refractory and recurrent BE cases require careful consideration of risk factors and salvage therapy.
Conclusions:
- Successful management of Barrett's esophagus (BE) relies on multimodal endoscopic eradication therapy (EET).
- Addressing modifiable risk factors like reflux is crucial for treatment success.
- Caution is advised regarding adverse effects, such as stricture formation, during salvage therapy for refractory BE.
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...

